MetLife Investment Management, LLC - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 161 filers reported holding ANIKA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$143,172
-28.3%
7,6850.0%0.00%0.0%
Q2 2023$199,656
-9.5%
7,6850.0%0.00%
-50.0%
Q1 2023$220,714
-3.0%
7,6850.0%0.00%0.0%
Q4 2022$227,476
+12.0%
7,685
-9.9%
0.00%0.0%
Q3 2022$203,014
+6.6%
8,5300.0%0.00%0.0%
Q2 2022$190,390
-11.1%
8,5300.0%0.00%
+100.0%
Q1 2022$214,188
+20.8%
8,530
+72.4%
0.00%
-50.0%
Q4 2021$177,287
-41.2%
4,948
-30.2%
0.00%
-33.3%
Q3 2021$301,623
-1.7%
7,0870.0%0.00%0.0%
Q2 2021$306,796
+6.1%
7,0870.0%0.00%0.0%
Q1 2021$289,079
-9.9%
7,0870.0%0.00%0.0%
Q4 2020$320,758
+27.9%
7,0870.0%0.00%0.0%
Q3 2020$250,809
-6.2%
7,0870.0%0.00%0.0%
Q2 2020$267,393
+30.5%
7,0870.0%0.00%0.0%
Q1 2020$204,885
-44.2%
7,0870.0%0.00%
-25.0%
Q4 2019$367,461
-5.5%
7,0870.0%0.00%0.0%
Q3 2019$389,005
+35.1%
7,0870.0%0.00%
+33.3%
Q2 2019$287,874
+34.3%
7,0870.0%0.00%
+50.0%
Q1 2019$214,311
-10.0%
7,0870.0%0.00%
-33.3%
Q4 2018$238,194
-20.3%
7,0870.0%0.00%0.0%
Q3 2018$298,930
+31.7%
7,0870.0%0.00%0.0%
Q2 2018$227,000
-35.5%
7,0870.0%0.00%
-25.0%
Q1 2018$352,000
-7.9%
7,0870.0%0.00%0.0%
Q4 2017$382,0007,0870.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders